97104 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
Sub-classes:IDENTIFICATION OF A HUMAN CIRCOVIRUS
#2NANOBODY, POLYPEPTIDE CONTAINING SAID NANOBODY AND USE THEREOF
#3Compositions and Methods for the Prevention and Treatment of Orthopoxvirus Infections
#4IgY ANTIBODIES TARGETING MONKEYPOX VIRUS AND METHODS OF USE THEREOF
#5RECOMBINANT ANTIBODIES, KITS COMPRISING THE SAME, AND USES THEREOF IN DIAGNOSING AFRICAN SWINE FEVER VIRUS
#6METHODS OF AAV THERAPY
#7IgY Antibody Compositions and Methods for Treating Mammal Species
#8SINGLE-DOMAIN ANTIBODY AGAINST CPV AND USES THEREOF
#9ANTI-VACCINIA VIRUS ANTIGEN ANTIBODIES AND RELATED COMPOSITIONS AND METHODS
#10CHIMERIC ANTIGEN RECEPTOR TARGETING ONCOLYTIC VIRUS-DERIVED PROTEIN, IMMUNOCYTE EXPRESSING SAME, AND USES OF BOTH
#11PARVOVIRUS ANTIBODY
#12METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS
#13COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS
#14PORCINE CIRCOVIRUS TYPE 3 IMMUNOGENIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#15METHOD FOR IDENTIFYING AND/OR REGULATING SENESCENCE
#16ADENOVIRUS IMMUNOASSAY METHOD AND ADENOVIRUS IMMUNOASSAY INSTRUMENT
#17SYSTEMS AND METHODS TO LINK CD40 SIGNALING TO ANTIGEN BINDING
#18METHODS OF BLOCKING / NEUTRALIZING ASFV INFECTION THROUGH INTERRUPTION OF CELLULAR AND VIRAL RECEPTOR INTERACTIONS
#19Biological Therapeutics for Infection-Relating Disorders or Conditions
#20METHODS AND COMPOSITIONS FOR RESTRICTING BIODISTRIBUTION OF AAV
#21ADENOVIRUS IMMUNIZATION MEASUREMENT METHOD AND IMMUNIZATION MEASUREMENT DEVICE
#22HIV-1 ANTIBODIES
#23NOVEL CELL LINE
#24CANINE PARVOVIRUS (CPV) NANOBODY CPV-VHH-H1 AND USE THEREOF
#25ADENOVIRUS IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT
#26VIRUS-LIKE PARTICLE BINDING AGENTS, RELATED COMPOSITIONS, AND RELATED METHODS
#27VACCINIA VIRAL POLYMERASE-MEDIATED VIRAL REPLICATION
#28ANTI-ONCOLYTIC VIRUS ANTIGEN ANTIBODIES AND METHODS OF USING SAME
#29TUMOR-TARGETING PROTEIN OR FRAGMENT THEREOF, ANTIBODY BINDING THERETO AND USE THEREOF
#30ENGINEERED IMMUNOGLOBULINS WITH ALTERED FCRN BINDING
#31PRODUCTION OF ANTI-VIRAL MONOCLONAL ANTIBODIES BY HYDRODYNAMIC-BASED TRANSFECTION
#32Parvovirus Antibodies for Veterinary Use
#33Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
#34METHODS OF BLOCKING ASFV INFECTION THROUGH INTERRUPTION OF CELLULAR AND VIRAL RECEPTOR INTERACTIONS
#35ANTIBODIES AGAINST AQUACULTURE DISEASE-CAUSING AGENTS AND USES THEREOF
#36TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS
#37Methods and compositions for antibody-evading virus vectors
#38ADENO-ASSOCIATED VIRUS ANTIBODIES AND FRAGMENTS THEREOF
#39Compositions and methods for treatment of neurological disorders
#40ASSAYS FOR THE DETECTION OF AAV NEUTRALIZING ANTIBODIES
#41Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
#42METHODS AND COMPOSITIONS FOR ENGINEERED ASSEMBLY ACTIVATING PROTEINS (EAAPS)
#43Fusion Proteins Comprising a Cell Surface Marker Specific VHH
#44Methods of AAV therapy
#45Mosaic chimeric viral vaccine particle
#46Methods and compositions for antibody-evading virus vectors
#47Hexon protein hypervariable region gene sequence of adenovirus and its application
#48Integral membrane protein display on poxvirus extracellular enveloped virions
#49MUTATED PARVOVIRUS STRUCTURAL PROTEINS AS VACCINES
#50APHERESIS METHODS AND USES
#51Tropism-Modified Recombinant Viral Vectors and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells
#52Mosaic chimeric viral vaccine particle
#53Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#54Human orthopoxvirus antibodies and methods of use therefor
#55Method for removing anti-AAV antibodies from a blood-derived composition
#56System for the biocontrol of pathogens in aquaculture and other animal systems
#57Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
#58Integral membrane protein display on poxvirus extracellular enveloped virions
#59Biological therapeutics for infection-relating disorders or conditions
#60METHOD FOR TREATING SOLUTION CONTAMINATED WITH PORCINE CIRCOVIRUSES
#61Hexon protein hypervariable region gene sequence of adenovirus and its application
#62Engineered immunoglobulins with altered FcRn binding
#63Monoclonal antibodies specific for the pIII antigen of human Adenovirus (ADV), produced and secreted by cell hybridomas, useful for detection and diagnosis of ADV infection
#64Methods and compositions for antibody-evading virus vectors
#65MONOCLONAL ANTIBODY SPECIFIC TO PCV2 AND METHOD FOR DIAGNOSING PMWS USING SAME
#66Assays for the detection of AAV neutralizing antibodies
#67Methods and compositions for combination immunotherapy
#68TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS
#69Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
#70Salmon gill poxvirus
#71Method for large scale production and purification of parvovirus
#72ENGINEERED HUMAN ANTI-AAV ANTIBODIES AND USES THEREOF
#73Treatment of ocular neovascularization using anti-VEGF proteins
#74Mosaic chimeric viral vaccine particle
#75Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#76Cytomegalovirus antigens and uses thereof
#77PATHOGEN DETECTION BY SERS NANOPARTICLES
#78Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same
#79Monoclonal antibodies against orthopoxviruses
#80Rearranged TT virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
#81Porcine parvovirus
#82Prophylactic vaccine against egg drop syndrome (EDS)
#83Adenovirus isolated from titi monkeys
#84Porcine torque teno virus vaccines and diagnosis
#85Canine health product containing antibodies against canine parvovirus type 2
#86Mutated parvovirus structural proteins as vaccines
#87ADENOVIRUSES AND THEIR USE
#88Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#89Antibody molecules
#90Biological therapeutics for infection-relating disorders or conditions
#91Method of Treating and Preventing Infectious Diseases Using Colostrum
#92Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof
#93MONOCLONAL ANTIBODIES AGAINST ORTHOPOXVIRUSES
#94Methods for the detection of JC polyoma virus
#95Human monoclonal antibody against the VP1 protein of JC virus
#96INTERFERON ANTAGONISTS, ANTIBODIES THERETO, AND ASSOCIATED METHODS OF USE
#97CYTOMEGALOVIRUS DISINTEGRIN-LIKE PEPTIDES
#98CANINE CIRCOVIRUS SEQUENCES AND USES THEREOF
#99Adenoviruses and their use
#100Treatment of ocular neovascularization using anti-VEGF proteins
#101INFECTIOUS CLONES OF TORQUE TENO VIRUS
#102Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#103Bovine adeno-associated viral (BAAV) vector and uses thereof
#104Rift Valley Fever Virus glycoproteins, Gn and Gc, and their use
#105Vaccinia virus H3L and B5R specific monoclonal antibodies and methods of making and using same
#106Parvovirus Vp1 unique region polypeptides and compositions thereof
#107Expression cassette for efficient surface display of antigenic proteins
#108Anthrax and small pox replikins and methods of use
#109BI-Specific Diabodies For Masking And Targeting Vaccines
#110NOVEL POLYMAVIRUS ASSOCIATED WITH DIARRHEA IN CHILDREN
#111Isolation, Cloning and Characterization of New Adeno-Associated Virus (AAV) Serotypes
#112HIGHLY POTENT PEPTIDES TO CONTROL CANCER AND NEURODEGENERATIVE DISEASES
#113REARRANGED TT VIRUS MOLECULES FOR USE IN DIAGNOSIS, PREVENTION AND TREATMENT OF CANCER AND AUTOIMMUNITY
#114Monoclonal antibodies against Orthopoxviruses
#115Modified parvovirus having enhanced anti-tumor efficacy
#116Methods of increasing efficiency of vector penetration of target tissue
#117METHODS FOR THE DETECTION OF JC POLYOMA VIRUS
#118Antibody that binds to H-1 parvovirus
#119Intravenous immunoglobulin composition
#120Infectious clones of torque teno virus
#121METHODS FOR THE DETECTION OF JC POLYOMA VIRUS
#122Bovine adeno-associated viral (BAAV) vector and uses thereof
#123INFECTIVITY-ENHANCED CONDITIONALLY-REPLICATIVE ADENOVIRUS AND USES THEREOF
#124Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof
#125Antibody composition with altered Fab sialylation
#126Monoclonal antibodies against orthopoxviruses
#127Anthrax and small Pox replikins and methods of use
#128ANTI-ORTHOPOXVIRUS RECOMBINANT POLYCLONAL ANTIBODY
#129Torque teno virus (TTV) isolates and compositions
#130Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma
#131Infectious clones of torque teno virus
#132LEPORIPOXVIRUS-DERIVED VACCINE VECTORS
#133Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#134Porcine torque teno virus vaccines and diagnosis
#135Interferon antagonists, antibodies thereto and associated methods of use
#136COMPOSITIONS AND PROCESSES RELATING TO HUMAN BOCAVIRUS
#137MUTATED PARVOVIRUS STRUCTURAL PROTEINS AS VACCINES
#138Secreted/cell bound poxvirus proteins and methods of use thereof as vaccines and anti-viral agents
#139Vaccinia virus H3L and B5R specific monoclonal antibodies and methods of making and using same
#140Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
#141Methods and compounds for lymphoma cell detection and isolation
#142Compositions, methods and kits relating to poxvirus subunit vaccines
#143COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF POXVIRAL INFECTIONS
#144ANTIBODY INHIBITING URACIL-DNA-GLYCOSYLASE AND USES THEREOF FOR DECONTAMINATING NUCLEIC ACID AMPLIFICATION REACTIONS
#145Compositions for the prevention and treatment of smallpox
#146Monoclonal antibodies against orthopoxviruses
#147Method for manufacturing a recombinant polyclonal protein
#148Modified plant viruses and methods of use thereof
#149Smallpox monoclonal antibody
#150Method for Obtaining Modified Proteins and Viruses with Intact Native Binding Site
#151Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
#152Anti-orthopoxvirus recombinant polyclonal antibody
#153Peptide originating from vaccinia virus
#154Methods and compounds for lymphoma cell detection and isolation
#155Anthrax and small pox replikins and methods of use
#156Oral use of specific antibodies for intestinal health
#157Bovine adeno-associated viral (BAAV) vector and uses thereof
#158Circovirus sequences associated with piglet weight loss disease (PWD)
#159Compositions and methods for inhibiting white spot syndrome virus (wssv) infection
#160Intravenous immunoglobulin composition
#161Circovirus sequences associated with piglet weight loss disease (PWD)
#162Method of promoting an immune response with a bispecific antibody
#163Compositions and methods modulating variola and vaccinia virus
#164Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection
#165Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
#166Compositions, methods and kits relating to poxvirus subunit vaccines
#167Porcine circovirus and Helicobacter combination vaccines and methods of use
#168Circovirus sequences associated with piglet weight loss disease (PWD)
#169Human antibodies for use as a therapeutic agent against vaccinia or small pox
#170Compositions for reducing virus infection rate in aquatic crustaceans and applications thereof
#171Compositions and methods modulating variola and vaccinia virus
#172Immunoglobulin having particular framework scaffold and methods of making and using
#173Nanobody against begomoviruses